NEWS
HOPE BTK registry reinforced the safety and efficacy of the company’s MagicTouch percutaneous transluminal angioplasty (PTA) sirolimus-coated balloon for treatment of below-the-knee (BTK) lesions.
Concept Medical (MagicTouch PTA 0.035 OTW) receives CE Mark for treatment of peripheral artery disease.
AWARDS
Concept Medical has officially been ranked among India’s Great Mid-size Workplaces 2025
Concept Medical Wins Times Healthcare Leaders 2025 awards for Innovation Excellence
Envisionscientific has achieved the prestigious ESG (Environmental, Social, and Governance) Certification!
PRESS RELEASE
02/08/2025
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe
21/01/2025
SirPAD – World’s largest RCT investigating MagicTouch PTA sirolimus coated balloon completes patient enrolment.
16/01/2025
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States
05/09/2025
Sirolimus Coated Balloon Associated with Superior 3-Year Outcomes Against POBA: Insights from The Hope BTK Registry